Translation. Region: Russian Federation –
Source: Moscow Government – Moscow Government –
An important disclaimer is at the bottom of this article.
The company, which began operations at a site in the Technopolis Moscow special economic zone (SEZ) in late 2024, is increasing its supply of high-tech medical products to the Russian market. By the end of 2025, the Elta plant will have produced over 10 million medical devices, according to the Deputy Mayor of Moscow for Transport and Industry. Maxim Liksutov.
"Following Sergei Sobyanin's instructions, the city is actively promoting the development of Moscow's industry. Thanks to a comprehensive set of effective city support measures, the Technopolis Moscow SEZ is successfully developing the production of high-tech medical devices and equipment. By the end of 2025, the company had produced approximately 600,000 glucometers and 10 million test strip packs. The company's development portfolio includes five glucose meter models, a lancing device, and a device for determining the percentage of glycated hemoglobin in the blood," noted Maxim Liksutov.
One of the company's flagship products is a smart glucometer with data transfer to a smartphone. The company has also created a dedicated mobile app that allows patients to send their monitoring results to their doctors.
The capital is increasing production of pharmaceutical substances.From Idea to Finished Product: How Moscow Startups Strengthen the Country's Technological Sovereignty
Currently, over 240 high-tech companies are located within the Technopolis Moscow SEZ, 128 of which are residents. They manufacture high-tech products, including modern pharmaceuticals, medical devices, microelectronics, machine tools, robotics, elevators, batteries, innovative products for the space industry, electric vehicle components, and new materials.
Get the latest news quickly on official Moscow messaging channels. MAX And Telegram.
Please note: This information is raw content obtained directly from the source. It represents an accurate account of the source's assertions and does not necessarily reflect the position of MIL-OSI or its clients.